RUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on ...
RUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack” or the "Company”), a medical technology company focused on the design, development, and ...
RUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design ... continuous blood glucose ...
This study represents first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...
Curbed on MSN1d
Making a Bar Look Like Baz LuhrmannNote the print on the right of The Witch, a 15th-century painting that Catherine Martin learned about studying for an ...
The artist, who died at 85, used Indigenous imagery like the canoe and the buffalo the way Warhol used soup cans. By Jillian Steinhauer Claire Tabouret, an artist in Los Angeles, was chosen to ...
Nov. 14, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design ... blood glucose monitor (“CBGM”) will be presented at the 24th An ...
Glucotrack (Nasdaq:GCTK) today said it hit a significant milestone in the development of its continuous blood glucose monitor (CBGM). Our sister site, Drug Delivery Business News, reports today ...
Glucotrack (Nasdaq:GCTK) announced today that it completed the first-in-human clinical study of its continuous blood glucose monitor (CBGM). The study included participants with both type 1 and type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback